
In continuation of stock exchange release no. 4 ? 2006/2007 of 10 January 2007 LMA has filed a patent infringement action against Ambu in the Netherlands in substitution of the withdrawn injunction proceedings.
Outcome of this case expected later this year. If LMA successfull they will be able to claim millions in damages from AMBU.
P/E ratio of 10 for LMA versus AMBU 23 seems also very low
LMA BUILDS DISTRIBUTION NETWORK FOR UROLOGY BUSINESS
Appoints exclusive distributor for LMA StoneBreakerTM in France
TM in FranceSingapore, 28 March 2007 ? Mainboard-listed LMA International NV (SGX: LMA), the global leader
in the development and marketing of the LMATM laryngeal mask airway range of supraglottic airway
management devices, announced that its subsidiary LMA Urology Suisse S.A. has entered into a
distribution agreement with EDAP TMS S.A. (?EDAP?) to exclusively distribute its innovative lithotripsy
device LMA StoneBreaker? in France.
EDAP, with more than 25 years of experience in sales and distribution, has a strong knowledge of the
medical community in France. The company has significant expertise in the domestic lithotripsy
market and a dedicated distribution network.
Paul Molloy, President of LMA Urology Suisse S.A., said, "LMA is very excited to be working with EDAP
in France where it is widely recognized as a pioneering and innovative market leader in the
distribution of innovative urinary medical systems. We are confident that the addition of our LMA
StoneBreaker? device to the EDAP portfolio will benefit both companies and bring a new standard of
care to those suffering from kidney stones.?
Marc Oczachowski, Chief Operating Officer of EDAP, added, ?We are pleased to work with LMA to
introduce the StoneBreaker? in France. EDAP has proved its ability to bring new therapeutic devices
to market and today benefits from a strong customer base and a supportive medical network, which
makes us confident of a successful launch for the LMA StoneBreaker?."
The LMA StoneBreaker? is a portable intra-corporeal contact lithotripter which effectively fragments
stones in the urinary tract. This handheld system complements lithotripsy procedures performed with
extracorporeal shock wave lithotripsy devices by targeting stones located in places which cannot be
reached with an extra-corporeal shockwave generator. The LMA StoneBreaker?, manufactured in
Switzerland, received the CE mark in June 2006 and is validated by extensive clinical trials confirming
the effectiveness of this device.
- Ends -
in the development and marketing of the LMATM laryngeal mask airway range of supraglottic airway
management devices, announced that its subsidiary LMA Urology Suisse S.A. has entered into a
distribution agreement with EDAP TMS S.A. (?EDAP?) to exclusively distribute its innovative lithotripsy
device LMA StoneBreaker? in France.
EDAP, with more than 25 years of experience in sales and distribution, has a strong knowledge of the
medical community in France. The company has significant expertise in the domestic lithotripsy
market and a dedicated distribution network.
Paul Molloy, President of LMA Urology Suisse S.A., said, "LMA is very excited to be working with EDAP
in France where it is widely recognized as a pioneering and innovative market leader in the
distribution of innovative urinary medical systems. We are confident that the addition of our LMA
StoneBreaker? device to the EDAP portfolio will benefit both companies and bring a new standard of
care to those suffering from kidney stones.?
Marc Oczachowski, Chief Operating Officer of EDAP, added, ?We are pleased to work with LMA to
introduce the StoneBreaker? in France. EDAP has proved its ability to bring new therapeutic devices
to market and today benefits from a strong customer base and a supportive medical network, which
makes us confident of a successful launch for the LMA StoneBreaker?."
The LMA StoneBreaker? is a portable intra-corporeal contact lithotripter which effectively fragments
stones in the urinary tract. This handheld system complements lithotripsy procedures performed with
extracorporeal shock wave lithotripsy devices by targeting stones located in places which cannot be
reached with an extra-corporeal shockwave generator. The LMA StoneBreaker?, manufactured in
Switzerland, received the CE mark in June 2006 and is validated by extensive clinical trials confirming
the effectiveness of this device.
- Ends -
management devices, announced that its subsidiary LMA Urology Suisse S.A. has entered into a
distribution agreement with EDAP TMS S.A. (?EDAP?) to exclusively distribute its innovative lithotripsy
device LMA StoneBreaker? in France.
EDAP, with more than 25 years of experience in sales and distribution, has a strong knowledge of the
medical community in France. The company has significant expertise in the domestic lithotripsy
market and a dedicated distribution network.
Paul Molloy, President of LMA Urology Suisse S.A., said, "LMA is very excited to be working with EDAP
in France where it is widely recognized as a pioneering and innovative market leader in the
distribution of innovative urinary medical systems. We are confident that the addition of our LMA
StoneBreaker? device to the EDAP portfolio will benefit both companies and bring a new standard of
care to those suffering from kidney stones.?
Marc Oczachowski, Chief Operating Officer of EDAP, added, ?We are pleased to work with LMA to
introduce the StoneBreaker? in France. EDAP has proved its ability to bring new therapeutic devices
to market and today benefits from a strong customer base and a supportive medical network, which
makes us confident of a successful launch for the LMA StoneBreaker?."
The LMA StoneBreaker? is a portable intra-corporeal contact lithotripter which effectively fragments
stones in the urinary tract. This handheld system complements lithotripsy procedures performed with
extracorporeal shock wave lithotripsy devices by targeting stones located in places which cannot be
reached with an extra-corporeal shockwave generator. The LMA StoneBreaker?, manufactured in
Switzerland, received the CE mark in June 2006 and is validated by extensive clinical trials confirming
the effectiveness of this device.
- Ends -
so does it mean you guys are collecting a lot right now at this price to average up your previous purchase?
Tks for the pointer and words of encouragement. Although LMA has a sufficiently strong economic moat, it still depends very much on the syndicates or operators to move it north, besides the FA factorWith increased volume and price today, a rebound seems imminent? Would any TA specialist care to comment?
Hi All,
Please be patient with this stock. Most punters (or investor) love stocks that are from countries that are hot (you know where they are) and have little faith with others (like this one in Holland). This way they can make more $$$.
Only when more ppl are shouting for LMA (wait for big guys like ML, UBS, Citi, or CLSA, etc etc) then it will have a big bump up.
Always remember, the more powerful the seller, the rebound will be greater.
Hope this helps
The price is definitely a bargain (bottomed out?). Shocking that an international brand like LMA has gone way below IPO price for such a LONG LONG time. It was just a lame excuse for LMA to dip below IPO price because LMA did not make a profit just after listing in 2005. The shares of other lesser known companies have managed to remain slightly below their IPO prices even when they are not profitable. With share buyback scheme already approved, LMA price has moved north - million thanks to the LMA directors!!!!!
"Ju ni yi lu shun feng"... :)
(Wish you smooth sailing"
Dear iPunter,
The price is accelerating now. I 'll keep buying till Sgd. 0.65!
My interest in this stock stems from Hikitty's undending support and loyalty for it.
To digress, it reminds me of Lin Dai's "Bu Liao Qing"...
I must watch the film again.
For FY 2006, LMA's net profit was US$22million. As it has turned around, growth potential as from 2007 onwards shd be good. The rebound should happen anytime soon - making up for lost time. Good luck to those patient investors of this "international brand" - it isn't a junk share, is it?